A screening engine, not a chart hunt.
KScreener reads de-identified EHR data, applies your protocol's eligibility logic, reasons through each match, and delivers a coordinator-ready patient list with rationale attached.
- De-identified EHR
- Lab values & diagnoses
- Medication history
- Prior treatment data
- Inclusion criteria
- Exclusion criteria
- Biomarker requirements
- Line-of-therapy rules
- Patient-by-patient review
- Structured + unstructured signals
- Criteria applied in sequence
- Match candidates surfaced
- Eligibility rationale
- Criteria-level explanation
- Evidence snippets
- Coordinator-defensible logic
- High-confidence matches
- Needs review
- Confidence ranking
- Coordinator-ready cohort
- Daily patient list
- Review-ready output
- Audit trail attached
Every matched patient is backed by the same screening logic.
Hover any stage to see how KScreener connects source data, protocol eligibility, reasoning, and coordinator-ready output into one defensible screening workflow.
Eligible patients are already in the chart.
They get missed because nobody has the time to read every record. Manual chart review is the bottleneck - and it's why a quarter of activated sites in any given trial enroll zero patients despite having the right population walking through the door.
The single most common cause of trial delay is the patient who never gets identified - sitting in a chart on the third floor of a hospital that already runs the trial.
A coordinator reviewing eligibility against a 30-criterion protocol averages 40 minutes per candidate. Most sites can't afford that across thousands of charts.
Half of patients who make it to a screening visit don't pass. The signal that would have stopped them was already in the chart.
A different way to screen patients.
Manual chart review depends on fragmented notes, inconsistent interpretation, and coordinator time. KScreener applies protocol eligibility logic consistently and returns patient matches with evidence and rationale attached.
From raw chart
to coordinator-ready.
KScreener is built for the regulated, de-identified, on-premise reality of working with EHR data. The reasoning happens at the site. The PHI doesn't move. The output ships every morning at 7am local.
Every match comes with its work shown.
A coordinator can trust an AI match exactly as far as they can defend it. Every KScreener candidate is shipped with a per-criterion rationale, a citation back to the source record, and a CRA-ready audit trail.
Built for the way real EHRs actually work.
The patient privacy posture isn't a slide deck. It's an architectural commitment - KScreener is engineered so that the most sensitive data stays at the site, even from us.
KScreener runs in the site's tenant. The only thing that crosses the boundary is the de-identified, tokenized worklist - never raw PHI.
Audit-ready by design. Every reasoning trace is hashed, every model version stamped, every coordinator action logged.
Tokens map back to MRNs only inside the site's EHR session. The platform itself never sees a name, a date of birth, or an address.
Standard IRB packet, BAA, and DPIA available out-of-the-box. Used in 40+ IRBs to date - your IRB has probably already seen us.
Real money, both sides of the table.
A faster trial is worth tens of millions to a sponsor and tens of thousands per month to a site. KScreener moves both numbers - and the second one is what makes the site network sustainable.
Median net cost avoidance per Phase II oncology trial - from compressed enrollment, reduced screen failures, and fewer rescue site activations.
- 5–7 month enrollment compression
- 60%+ reduction in screen failures
- Better representation across catchment
Reported range of incremental annual revenue across Kitsa network sites - from higher match rates, more trials placed, and reduced coordinator overhead.
- Coordinator hours redirected to consenting
- Auto-matched to incoming sponsor RFPs
- Performance score travels across studies
“We used to spend three weeks finding ten patients. Now we get the worklist at 7am. The screen-fail rate went from 51% to 14%, and the coordinators actually have time to talk to families again.”
Questions, answered.
Bring faster patient screening forward.
See how KScreener helps teams match eligible patients to the right clinical trials with secure, AI-assisted screening workflows.
Request a demo →